Intrinsiqs

Is DexCom, Inc. overvalued?

DexCom, Inc. (DXCM) looks fairly valued — trading about 4% below its fair value.

Fairly valued
Current price $90.80 Fair value $94.05
Price
$90.80
Fair value
$94.05
Current P/E
43.4
Normal P/E
45.0
Market cap
$34.26B
Dividend yield
0.0%
Return on equity
36.2%
Sector
Healthcare

See the full interactive analysis →

Fair value compares DXCM's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.UNH UnitedHealth Group IncorporatedRHHBY Roche Holding AGMRK Merck & Co., Inc.